Autolus Therapeutics (AUTL) Misses Q3 EPS by 10c

Autolus Therapeutics (NASDAQ: AUTL) reported Q3 EPS of ($0.31), $0.10 worse than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• ASM International NV (ASM:NA) PT Raised to EUR1,174 at JPMorgan
• Blue Star Gold closes final tranche of flow-through private placement